New England Private Wealth Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
WAM
FHA
CA
KIM
AAM
New England Private Wealth Advisors's HQL Position: Q4 2019 in Review
New England Private Wealth Advisors sold out of abrdn Life Sciences Investors (HQL) in Q4 2019, closing a stake of 13,181 shares — an estimated $199K sold.
New England Private Wealth Advisors first reported a position in HQL in Q4 2013 and held it in 20 quarters. The position peaked at $344K in Q4 2013. 69 funds tracked by Wall St. Rank hold HQL as of Q4 2019.
- New England Private Wealth Advisors reported no remaining abrdn Life Sciences Investors position as of Q4 2019 after selling out during the quarter.
- New England Private Wealth Advisors sold 13,181 abrdn Life Sciences Investors shares in Q4 2019, an estimated $199K.
- New England Private Wealth Advisors first reported a position in abrdn Life Sciences Investors in Q4 2013 and held it in 20 quarters.
- New England Private Wealth Advisors's abrdn Life Sciences Investors position peaked at $344K in Q4 2013.
- 69 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2019.
Based on New England Private Wealth Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.